Neuromodulation start-up closes EUR 15M Series C financing round
First expandable percutaneous lead for neuromodulation treatment of chronic pain
06-Oct-2020 -
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, announced the closing of a EUR 15 million Series C financing round. New investors, led by CDP Venture Capital SGR, and including Indaco Ventures I ...
chronic pain
implants
neuromodulation
+1